key highlights in mpns: novel agents, combinations, and the potential role of immunotherapy
Published 1 year ago • 304 plays • Length 13:31Download video MP4
Download video MP3
Similar videos
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
6:43
key highlights in cll: clinical trial updates & the role of combination therapies and novel btkis
-
9:53
key highlights in amyloidosis at ash 2023: diagnosis & novel immunotherapeutic agents being explored
-
2:12
novel targets and combinations being explored in mpns
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:44
upcoming trials and novel agents in mpns
-
1:46:07
hematology lecture
-
28:08
dr. gaby hobbs, md: diagnosis and initial treatment options for et, pv & mf
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
1:33
the need for novel therapeutic agents in myeloproliferative neoplasms
-
4:45
phase ib/ii multi-arm study of combinations of novel agents in r/r aml
-
2:43
the management of advanced phase mpns
-
1:14
promising novel agents in aml: menin inhibitors
-
26:22
key takeaways in mpns
-
0:35
the importance of bridging therapy in follicular and mantle cell lymphoma
-
2:41
an overview of the latest advances in hematology
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:14
an overview of the current and future treatment landscape for mpns